Metraipolis › archive › dc_b4efd86809d6

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives — Europe PMC PMID:41930147

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41930147
DOI
10.32604/or.2025.073554
License (as archived)
solo-consultazione
Archived
2026-11-04T02:12:58.418Z
SHA-256 of the archived text
4a871823dadfcd1c1750a05c0aa220288348f80653679f706754f62977661b78
Stable URL of this page
https://metraipolis.com/documento/dc_b4efd86809d6

How to cite

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives — Europe PMC PMID:41930147 — Europe PMC (en), https://europepmc.org/article/MED/41930147 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4efd86809d6 (Metraipolis archive dc_b4efd86809d6, sha256 4a871823dadfcd1c1750a05c0aa220288348f80653679f706754f62977661b78)
BibTeX
@misc{dcb4efd86809d6,
  title = {Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives — Europe PMC PMID:41930147},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41930147},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4efd86809d6; sha256 4a871823dadfcd1c1750a05c0aa220288348f80653679f706754f62977661b78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930147. Agents can read the archived copy with the MCP tool read_document.